Open AccessAn Interesting Experience with Empagliflozin: Unidentified Body Odor
Author(s) -
Oğuz Abdullah Uyaroğlu
Publication year - 2021
Publication title -
acta endocrinologica (bucharest)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 13
eISSN - 1843-066X
pISSN - 1841-0987
DOI - 10.4183/aeb.2021.554
Subject(s) - empagliflozin , adverse effect , medicine , odor , metformin , discontinuation , type 2 diabetes , diabetes mellitus , endocrinology , psychology , neuroscience
Sodium-glucose co-transporter 2 inhibitors (SGLT2-I) are a new class of oral antidiabetic drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom